Evidence map›Paper›PMID 35883753›Full record

ReviewAntioxidants (Basel, Switzerland)2022

Cold Argon Athmospheric Plasma for Biomedicine: Biological Effects, Applications and Possibilities.

Andrew K Martusevich, Alexandra V Surovegina, Ivan V Bocharin, Vladimir V Nazarov, Inessa A Minenko, Mikhail Yu Artamonov

Registry-linked trialAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06435533 (Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06435533 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis

TypeinterventionalSponsorUniversitätsklinikum Hamburg-EppendorfRan2023 to 2025Enrolled10ConditionsAdenomatous Polyposis Coli, Familial Adenomatous Polyposis, Duodenal AdenomaArmslow energy argonplasma coagulation
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew K MartusevichLaboratory of Translational Free Radical Biomedicine, Sechenov University, 119991 Moscow, Russia.ORCID 0000-0002-0818-5316
Alexandra V SuroveginaLaboratory of Translational Free Radical Biomedicine, Sechenov University, 119991 Moscow, Russia.
Ivan V BocharinLaboratory of Medical Biophysics, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia.
Vladimir V NazarovLaboratory of Translational Free Radical Biomedicine, Sechenov University, 119991 Moscow, Russia.
Inessa A MinenkoLaboratory of Translational Free Radical Biomedicine, Sechenov University, 119991 Moscow, Russia.
Mikhail Yu ArtamonovLaboratory of Translational Free Radical Biomedicine, Sechenov University, 119991 Moscow, Russia.

Funding

Russian Science Foundation 22-25-00652Sechenov University («Priority 2030» program)
6 · The paper itself

Abstract

Currently, plasma medicine is a synthetic direction that unites the efforts of specialists of various profiles. For the successful formation of plasma medicine, it is necessary to solve a large complex of problems, including creating equipment for generating cold plasma, revealing the biological effects of this effect, as well as identifying and justifying the most promising areas of its application. It is known that these biological effects include antibacterial and antiviral activity, the ability to stimulate hemocoagulation, pro-regenerative properties, etc. The possibility of using the factor in tissue engineering and implantology is also shown. Based on this, the purpose of this review was to form a unified understanding of the biological effects and biomedical applications of argon cold plasma. The review shows that cold plasma, like any other physical and chemical factors, has dose dependence, and the variable parameter in this case is the exposure of its application. One of the significant characteristics determining the specificity of the cold plasma effect is the carrier gas selection. This gas carrier is not just an ionized medium but modulates the response of biosystems to it. Finally, the perception of cold plasma by cellular structures can be carried out by activating a special molecular biosensor, the functioning of which significantly depends on the parameters of the medium (in the field of plasma generation and the cell itself). Further research in this area can open up new prospects for the effective use of cold plasma.

Indexed as

argonbiological effectscold plasmamolecular mechanisms of action

Identifiers

PMID35883753
PMCPMC9311881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.